dr. lee on b-cell receptor targeting in relapsed/refractory mcl
Published 4 years ago • 111 plays • Length 1:35Download video MP4
Download video MP3
Similar videos
-
1:25
dr. lee on early efficacy data with cirmtuzumab/ibrutinib in relapsed/refractory mcl
-
1:22
dr. lee on the mechanism of action of cirmtuzumab in mcl or cll
-
1:47
dr. leslie on the role of btk inhibitors in relapsed/refractory mcl
-
2:04
dr lee dr. lee on examining novel targets in lymphomas and leukemias
-
1:22
dr. leslie on sequencing zanubrutinib in mcl
-
43:11
rare t-cell lymphomas overview | lrf ed forum series
-
39:14
lg pathlab webinars: basic approach to lymph node for lymphoma (small mature b small cell)
-
47:23
lymphoplasmacytic neoplasms: cases and differentials
-
1:02
dr. goy on the progression of mcl treatment
-
3:31
nccn guidelines for relapsed/refractory mcl
-
1:01
dr. ritchie on the rationale of the aim trial in relapsed/refractory mantle cell lymphoma
-
1:20:06
update on relapsed/refractory mantle cell lymphoma | lrf webinars
-
1:03
dr. maddocks on the role of zanubrutinib in b-cell malignancies
-
4:06
identifying unmet needs in relapsed/refractory mcl
-
3:21
an integrated view of the role of the b cell antigen receptor in lymphoma cell fitness
-
1:19:12
the next phase of targeted therapy in mcl and dlbcl
-
1:13
dr. goy on research efforts with btk inhibitors in mcl
-
20:02
what are the hurdles to using cell of origin in classification to treat dlbcl?
-
16:20
molecular mechanisms of mcl and their targeting with novel agents
-
1:10
dr. shah on overcoming resistance to btk inhibitors in mcl
-
1:04
ft516: a novel nk cell therapy targeting b-cell lymphoma
-
5:00
b cell receptor (bcr) (fl-immuno/47)